Vimarsana
Biggest News Aggregation in the World

Page 6 - Alector News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alector. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alector Today - Breaking & Trending Today

Insider Selling: Alector, Inc. (NASDAQ:ALEC) CEO Sells $36,259.50 in Stock - Vimarsana News

Insider Selling: Alector, Inc. (NASDAQ:ALEC) CEO Sells $36,259.50 in Stock

Alector, Inc. (NASDAQ:ALEC – Get Rating) CEO Arnon Rosenthal sold 5,255 shares of Alector stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $6.90, for a total value of $36,259.50. Following the transaction, the chief executive officer now directly owns 1,651,095 shares in the company, […]

Source: wkrb13.com
Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference - Vimarsana News

Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., June 06, 2023 -- Alector, Inc. , a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will participate in a fireside chat... | June 6, 2023

Many Biotechs Are Worth More Dead Than Alive - Vimarsana News

Many Biotechs Are Worth More Dead Than Alive

There are 23 biotechs with negative enterprise values in the XBI and the iShares Biotechnology ETFs.

Alector, Inc. (NASDAQ:ALEC) Receives Average Rating of "Moderate Buy" from Brokerages - Vimarsana News

Alector, Inc. (NASDAQ:ALEC) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Alector, Inc. (NASDAQ:ALEC – Get Rating) have received an average rating of “Moderate Buy” from the eight brokerages that are covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among […]

Alector (NASDAQ:ALEC) Price Target Cut to $12.00 - Vimarsana News

Alector (NASDAQ:ALEC) Price Target Cut to $12.00

Alector (NASDAQ:ALEC – Get Rating) had its price objective cut by Barclays from $14.00 to $12.00 in a research report report published on Friday, The Fly reports. Other research analysts have also issued reports about the company. BTIG Research decreased their price objective on Alector from $54.00 to $16.00 and set a buy rating on […]

Source: wkrb13.com